Seven Eight Capital, LP Amicus Therapeutics, Inc. Transaction History
Seven Eight Capital, LP
- $1.05 Billion
- Q3 2024
A detailed history of Seven Eight Capital, LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 152,604 shares of FOLD stock, worth $1.47 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
152,604
Previous 152,511
0.06%
Holding current value
$1.47 Million
Previous $1.51 Million
7.74%
% of portfolio
0.15%
Previous 0.16%
Shares
21 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
312MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$278 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$271 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$235 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$231 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$224 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.71B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...